Nuzenio

Abiraterone

Abiraterone news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 3 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Practical Implementation of Capivasertib-Abiraterone for PTEN-Deficient mHSPC - Zachary Klaassen, Brenda Martone, Kara Cossis & Christina Lee - UroTodayUroToday · Mon, 10 Aug 2026 20:18:54 GMTCAPItello-281 Trial Design and Efficacy Data in mHSPC - Urology TimesUrology Times · Thu, 06 Aug 2026 12:08:03 GMTComment on “Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial” - Springer Nature LinkSpringer Nature Link · Sun, 02 Aug 2026 08:28:17 GMT

Timeline

Mon, 10 Aug 2026 20:18:54 GMTPractical Implementation of Capivasertib-Abiraterone for PTEN-Deficient mHSPC - Zachary Klaassen, Brenda Martone, Kara Cossis & Christina Lee - UroToday
Thu, 06 Aug 2026 12:08:03 GMTCAPItello-281 Trial Design and Efficacy Data in mHSPC - Urology Times
Sun, 02 Aug 2026 08:28:17 GMTComment on “Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial” - Springer Nature Link

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Abiraterone.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.